Self-reported pediatricians' management of the well-appearing young child with fever without a source: First survey in an European country in the anti-pneumococcal vaccine era

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Chiappini, Elena ^a   Galli, Luisa ^a   Bonsignori, Francesca ^a   Venturini, Elisabetta ^a   Principi, Nicola ^a,b   De Martino, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; C REACTIVE PROTEIN; CEFTRIAXONE; CEPHALOSPORIN; MACROLIDE; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL DECISION MAKING; ERYTHROCYTE SEDIMENTATION RATE; EUROPE; FEMALE; HEALTH SURVEY; HUMAN; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; PEDIATRICIAN; PRIMARY MEDICAL CARE; PYREXIA IDIOPATHICA; SELF REPORT; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FEVER; MANPOWER; PEDIATRICS; PRESCHOOL CHILD;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEVER; HUMANS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PNEUMOCOCCAL VACCINES;

EID: 69949176727     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-300     Document Type: Article

References (23)

1. Fever without apparent source on clinical examination. B Antonyrajah D Mukundan, CurrOpin Pediatr 2008 20 96 102
2. Management of fever without source in infants and children. LJ Baraff, Ann Emerg Med 2000 36 602 14
3. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. ME Pichichero JR Casey, JAMA 2007 298 1772 8
4. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. HE Hsu KA Shutt BW Beall NM Bennett AS Craig MM Farley JH Jorgensen CA Lexau S Petit A Reingold W Schaffner A Thomas CG Whitney LH Harrison, New Engl J Med 2009 360 244 56
5. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. MR Moore RE Gertz RL Woodbury GA Barkocy-Gallagher W Schaffner C Lexau K Gershman A Reingold M Farley LH Harrison JL Hadler NM Bennet AR Thomas L McGee T Pilishvili AB Brueggemann CG Whitney JH Jorgensen B Beall, J Infect Dis 2008 197 1016 22
6. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. LA Hickes LH Harrison B Flannery JL Hadler W Schaffner AS Craig D Jackson A Thomas B Beall R Lynfield A Reingold MM Farley CG Whitney, J Infect Dis 2007 196 1346 54
7. Management of febrile children in the conjugate pneumococcal vaccine era. ME Gabriel L Aiuto N Kohn SR Barone, Clin Pediatr 2004 43 75 82
8. Pediatricians' self-reported clinical practices and adherence to national vaccination guidelines after the introduction of pneumococcal conjugate vaccine. KC Lee JA Finkelstein IL Miroshnik D Rusinak JM Santoli SM Lett TA Lieu, Arch Pediatr Adolesc Med 2004 158 695 701
9. Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. S Esposito S Bosis C Pelucchi E Begliatti A Rognoni M Bellasio F Tel S Consolo N Principi, Vaccine 2007 25 6437 46
10. A survey about management of febrile children without source by primary care physicians. RR Wittler KK Cain JW Bass, Pediatr Infect Dis J 1998 17 271 79576380
11. Management of infants and children 3 to 36 months of age with fever without source. LJ Baraff, Pediatr Ann 1993 22 497 8
12. Fever without source in children 0 to 36 months of age. P Ishimine, Pediatr Clin North Am 2006 53 167 94
13. ACEP Clinical Policies Committee and the Clinical Policies Committee and the Clinical Policies Subcommittee on Pediatric Fever, Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med 2003 42 530 45
14. Feverish illness: assessment and initial management in children younger than 5 years. National Institute for Health and Clinical Excellence, London: NICE 2007 http://www.nice.org.uk/CG047 Accessed May 10, 2008
15. Evaluating fever of unidentifiable source in young children. DK Sur EL Bukont, Am Fam Physician 2007 75 1805 11
16. One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. MM Davis SM Ndiaye GL Freed SJ Clark, J Am Board Fam Pract 2003 16 363 71
17. Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006. F Montagnani A Fanetti L Stolzuoli L Croci F Arena A Zanchi C Cellesi, J Infect 2008 56 179 84
18. Parenteral vs oral antibiotics in the prevention of serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a meta-analysis. SG Rothrock SM Green MB Harper, Acad Emerg Med 1998 5 599 606 9660287
19. Evidence of self-report bias in assessing adherence to guidelines. AS Adams SB Soumerai J Lomas D Ross-Degnan, Int J Qual Health Care 1999 11 187 192
20. Impact of the pneumococcal conjugate vaccine in the management of highly febrile children aged 6 to 24 months in an emergency department. S Mintegi J Benito M González E Astobiza J Sanchez M Santiago, Pediatr Emerg Care 2006 22 566 9
21. Active Bacterial Core surveillance. Streptococcus pneumoniae surveillance reports. Centers for Disease Control and Prevention, http://www.cdc.gov/ncidod/ dbmd/abcs/survreports.htm Accessed May 10, 2008
22. Invasive pneumococcal disease: the target is moving. TR Peters KA Poehling, JAMA 2007 297 1825 6
23. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. RJ Singleton TW Hennessy LR Bulkow LL Hammitt T Zulz DA Hurlburt JC Butler K Rudolph A Parkinson, JAMA 2007 297 1784 92